AstraZeneca opened its global headquarters and research and discovery centre at the £1billion Discovery Centre (the DISC) on ...

AstraZeneca (Cambridge, U.K.) announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines ...

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

The U.K. biopharmaceutical giant’s plans include a proposal for a new drug substance manufacturing center focused on ...

A review of the last 10 years of partnership focusing on scientific collaboration, nurturing talent and strengthening our ecosystem.

Virginia facility investment will be AstraZeneca’s largest yet. Maryland, Massachusetts, California, Indiana, Texas projects ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

AstraZeneca said the “cornerstone” of the commitment would be a new weight management production facility for its oral GLP-1 ...

AstraZeneca <AZN.L> is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources ...